The main objective of Rare Disease Day is to raise public awareness of rare diseases
Viapath’s Rare Disease Day event, focused on phenylketonuria (PKU), a disease that affects 1 in 10,000 babies a year and is diagnosed through the Newborn Bloodspot Screening programme
Haemostasis is the balance of maintaining blood in a fluid state within blood vessels and limiting blood loss after trauma
The imbalance of coagulation factors can have implications in disease states such as venous thromboembolism, atherothrombosis or cardioembolic stroke
One-stage factor assays are used to determine whether a patient has sufficient coagulation activity to maintain haemostasis
Analysis of an unknown substance can be extremely useful in clinical diagnosis.
Substances ranging from powders and pills to herbal material, cigarette stubs and liquids can be analysed using high-resolution accurate mass spectrometry.
Viapath’s Toxicology Laboratory determined the components of a ‘diet pill’ bought online.
Diagnosis of skin cancer, and in particular non–melanoma skin cancer, has been steadily increasing.
Current methods for frozen tissue sectioning are inadequate and imprecise
Dr Guy Orchard gives an assessment of two new pieces of equipment on offer that are proposed to improve efficiency and accuracy in histology
Working with our NHS service partners to set the standard for the future of pathology
Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. www.pathologyassociation.com
Copyright 2014 Viapath Group LLP. Viapath and the Viapath logo are registered trademarks of Viapath Group LLP.